Stock listing
NASDAQ:KRMD KORU Medical Systems, Inc. Stock
Home listing (NASDAQ) of KORU Medical Systems, Inc.
Follow KORU Medical Systems, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:KRMD
$3.19 USD -0.26 (-7.5%)
Close on Nov 20, 2026
- Day range
- $3.17 – $3.48 USDNov 20, 2026
- Volume
- 320,881 sharesNov 20, 2026
- Market cap
- $147.3M USDAt the close on Nov 20, 2026 · price × 46.17M shares outstanding
- 52-week range
- $2.86 – $6.61 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $724,135 USDMedian day 183,800 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KRMD · Home | $3.19 USD | -0.26 (-7.5%) | 320,881 | $3.42 | $3.48 | $3.17 | $3.45 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:KRMD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.19 | -0.26 | -7.5% | $3.42 | $3.48 | $3.17 | 320,881 | |
| $3.45 | -0.04 | -1.1% | $3.51 | $3.585 | $3.405 | 191,163 | |
| $3.49 | -0.20 | -5.4% | $3.68 | $3.72 | $3.45 | 168,485 | |
| $3.69 | -0.01 | -0.3% | $3.65 | $3.73 | $3.55 | 448,809 | |
| $3.70 | +0.01 | +0.3% | $3.66 | $3.80 | $3.51 | 219,097 | |
| $3.69 | -0.20 | -5.1% | $3.86 | $4.07 | $3.66 | 352,227 | |
| $3.89 | +0.73 | +23.1% | $3.32 | $3.965 | $3.30 | 722,940 | |
| $3.16 | -0.07 | -2.2% | $3.22 | $3.22 | $3.07 | 207,911 | |
| $3.23 | +0.14 | +4.5% | $3.14 | $3.24 | $3.00 | 154,835 | |
| $3.09 | +0.06 | +2.0% | $3.10 | $3.107 | $2.95 | 105,437 | |
| $3.03 | -0.24 | -7.3% | $3.31 | $3.31 | $2.92 | 143,732 | |
| $3.27 | +0.17 | +5.5% | $3.18 | $3.29 | $3.13 | 125,464 | |
| $3.10 | +0.05 | +1.6% | $3.05 | $3.13 | $2.99 | 109,077 | |
| $3.05 | +0.06 | +2.0% | $3.03 | $3.16 | $2.99 | 221,696 | |
| $2.99 | -0.24 | -7.4% | $3.24 | $3.245 | $2.99 | 165,219 | |
| $3.23 | +0.01 | +0.3% | $3.25 | $3.31 | $3.21 | 84,125 | |
| $3.22 | +0.05 | +1.6% | $3.17 | $3.24 | $3.13 | 84,462 | |
| $3.17 | +0.05 | +1.6% | $3.14 | $3.19 | $3.05 | 128,855 | |
| $3.12 | -0.05 | -1.6% | $3.18 | $3.27 | $3.10 | 175,983 | |
| $3.17 | +0.095 | +3.1% | $3.06 | $3.19 | $3.05 | 163,000 | |
| $3.075 | -0.035 | -1.1% | $3.11 | $3.14 | $3.05 | 84,500 | |
| $3.11 | +0.07 | +2.3% | $3.04 | $3.155 | $2.995 | 135,600 | |
| $3.04 | +0.02 | +0.7% | $3.04 | $3.09 | $2.98 | 108,400 | |
| $3.02 | +0.02 | +0.7% | $2.99 | $3.045 | $2.92 | 161,200 | |
| $3.00 | -0.03 | -1.0% | $3.03 | $3.055 | $2.96 | 165,200 | |
| $3.03 | -0.08 | -2.6% | $3.12 | $3.14 | $2.97 | 203,200 | |
| $3.11 | +0.11 | +3.7% | $2.97 | $3.11 | $2.89 | 315,700 | |
| $3.00 | +0.03 | +1.0% | $2.97 | $3.045 | $2.929 | 318,000 | |
| $2.97 | +0.01 | +0.3% | $2.96 | $2.97 | $2.87 | 162,900 | |
| $2.96 | -0.04 | -1.3% | $2.99 | $3.07 | $2.94 | 202,600 | |
| $3.00 | +0.02 | +0.7% | $2.97 | $3.05 | $2.95 | 235,900 | |
| $2.98 | -0.02 | -0.7% | $2.98 | $3.045 | $2.96 | 111,000 | |
| $3.00 | -0.01 | -0.3% | $3.02 | $3.02 | $2.95 | 129,100 | |
| $3.01 | +0.05 | +1.7% | $2.99 | $3.025 | $2.91 | 206,400 | |
| $2.96 | -0.06 | -2.0% | $3.11 | $3.255 | $2.94 | 273,500 | |
| $3.02 | +0.09 | +3.1% | $2.94 | $3.04 | $2.86 | 280,400 | |
| $2.93 | -0.075 | -2.5% | $3.02 | $3.02 | $2.90 | 265,700 | |
| $3.005 | -0.055 | -1.8% | $3.04 | $3.05 | $2.98 | 243,100 | |
| $3.06 | -0.15 | -4.7% | $3.21 | $3.245 | $3.015 | 226,700 | |
| $3.21 | -0.06 | -1.8% | $3.27 | $3.30 | $2.99 | 368,600 | |
| $3.27 | 0.00 | 0.0% | $3.26 | $3.29 | $3.18 | 357,000 | |
| $3.27 | -0.04 | -1.2% | $3.31 | $3.39 | $3.20 | 465,600 | |
| $3.31 | +0.08 | +2.5% | $3.25 | $3.325 | $3.20 | 611,500 | |
| $3.23 | 0.00 | 0.0% | $3.23 | $3.27 | $3.20 | 265,300 | |
| $3.23 | +0.01 | +0.3% | $3.18 | $3.245 | $3.062 | 676,700 | |
| $3.22 | +0.02 | +0.6% | $3.23 | $3.23 | $3.15 | 174,900 | |
| $3.20 | +0.04 | +1.3% | $3.16 | $3.22 | $3.13 | 316,300 | |
| $3.16 | +0.02 | +0.6% | $3.14 | $3.17 | $3.09 | 183,800 | |
| $3.14 | -0.02 | -0.6% | $3.16 | $3.18 | $3.122 | 163,300 | |
| $3.16 | +0.01 | +0.3% | $3.18 | $3.19 | $3.14 | 129,500 | |
| $3.15 | 0.00 | 0.0% | $3.23 | $3.24 | $3.12 | 160,200 | |
| $3.15 | -0.02 | -0.6% | $3.21 | $3.27 | $3.12 | 180,600 | |
| $3.17 | -0.08 | -2.5% | $3.22 | $3.22 | $3.115 | 292,500 | |
| $3.25 | +0.03 | +0.9% | $3.22 | $3.30 | $3.16 | 116,600 | |
| $3.22 | -0.08 | -2.4% | $3.34 | $3.34 | $3.21 | 153,600 | |
| $3.30 | 0.00 | 0.0% | $3.30 | $3.43 | $3.30 | 212,500 | |
| $3.30 | 0.00 | 0.0% | $3.30 | $3.36 | $3.27 | 132,700 | |
| $3.30 | +0.07 | +2.2% | $3.20 | $3.315 | $3.20 | 172,900 | |
| $3.23 | +0.03 | +0.9% | $3.20 | $3.26 | $3.19 | 143,800 | |
| $3.20 | -0.01 | -0.3% | $3.21 | $3.24 | $3.17 | 141,500 | |
| $3.21 | 0.00 | 0.0% | $3.21 | $3.22 | $3.16 | 161,400 | |
| $3.21 | -0.01 | -0.3% | $3.22 | $3.24 | $3.175 | 205,506 | |
| $3.22 | +0.01 | +0.3% | $3.24 | $3.28 | $3.14 | 186,118 | |
| $3.21 | -0.06 | -1.8% | $3.27 | $3.295 | $3.20 | 234,800 | |
| $3.27 | -0.05 | -1.5% | $3.32 | $3.37 | $3.25 | 238,300 |
- Ticker
- NASDAQ:KRMD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 10, 2026
KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA
Latest earnings call · Nov 10, 2026
KORU Medical Systems (NASDAQ:KRMD) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 10, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Latest news
KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA
Nov 10, 2026
Closed $3.89 (+23.1%) on Nov 11, 2026
KORU Medical Systems to Participate in Upcoming Investor Conferences
Nov 4, 2026
Closed $3.03 (-7.3%) on Nov 5, 2026
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026
Oct 20, 2026
Closed $3.11 (+2.3%) on Oct 21, 2026
KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance: : KORU Medical Systems (KRMD)
Aug 5, 2026
Closed $3.56 (-13.8%) on Aug 6, 2026
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
Jul 29, 2026
Closed $4.11 (+1.0%) on Jul 30, 2026
KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026: : KORU Medical Systems (KRMD)
Jul 15, 2026
Closed $4.24 (+2.7%) on Jul 16, 2026
KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul 15, 2026
Closed $4.24 (+2.7%) on Jul 16, 2026
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
May 18, 2026
Closed $3.96 (+3.4%) on May 19, 2026
KORU Medical Systems Announces First Quarter 2026 Results
May 6, 2026
Closed $4.44 (+10.7%) on May 7, 2026
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
Apr 16, 2026
Closed $4.18 (-1.6%) on Apr 16, 2026
KORU Medical Systems, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 21 in the last 12 months · 123 in all · newest Nov 10, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Nov 10, 2026
- Decks
- 20 decks · latest Nov 10, 2026
Where KORU Medical Systems, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KRMD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:KRMD | BOATS | United States | USD |
Valuation
EV/sales 68,440× against a median of 2.6×: the highest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $3.17T USD
- P/E
- Loss
- EV/sales
- 68,440×
- EV/EBITDA
- 15,926,569×
- Price/book
- 7.6×
- Gross margin
- 63.6%
- Operating margin
- −1.3%
- Net margin
- −1.8%
- Debt to equity
- 163,275×
- Beta vs S&P 500
- 1.06
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| KORU Medical Systems, Inc. · NASDAQ:KRMD | US$147.3M | US$3.17T | n/a | 68,440× | 15,926,569× | 7.6× | −1.8% | 163,275× | 1.06 |
| Pacific Hospital Supply Co., Ltd. · TPEX:4126 | US$158.8M | US$116.7M | 12.1× | 1.6× | 6.3× | 1.8× | 17.9% | 0.0× | n/a |
| PW Medtech Group Ltd. · HKEX:1358 | US$156.6M | −US$114.6M | 11.1× | −0.9× | −2.9× | 0.3× | 11.5% | 0.0× | n/a |
| CUREXO Inc. · KRX:060280 | US$152.5M | US$133.1M | 37.2× | 2.3× | 29.7× | 2.0× | 7.1% | 0.0× | n/a |
| Delta Asia International Corporation · TPEX:6762 | US$151.3M | US$152.0M | 213× | 7.2× | 18.2× | 3.8× | 3.4% | 0.2× | n/a |
| Paxman AB · OMXSTO:PAX | US$146.5M | US$137.3M | n/a | 3.8× | 36.9× | 3.6× | −1.4% | 0.0× | n/a |
| Nextbiomedical Co. Ltd. · KRX:389650 | US$146.4M | US$120.9M | 847× | 9.1× | n/a | 4.0× | 1.3% | 0.0× | n/a |
| TriSalus Life Sciences, Inc. · NASDAQ:TLSI | US$143.1M | US$134.5M | n/a | 2.9× | n/a | 211× | −56.6% | 47.6× | 1.22 |
| Inogen, Inc · NASDAQ:INGN | US$140.7M | US$58.75M | n/a | 0.2× | n/a | 0.9× | −10.1% | 0.1× | 0.64 |
| Asterasys Co., Ltd. · KRX:450950 | US$138.3M | US$124.7M | 30.6× | 4.2× | 26.8× | 4.1× | 15.4% | 0.0× | n/a |
| Hans Biomed Corp · KRX:042520 | US$135.1M | US$125.0M | n/a | 1.4× | n/a | 2.3× | −15.8% | 0.1× | n/a |
| Median of the others | US$146.4M | US$124.9M | 33.9× | 2.6× | 22.5× | 3.0× | 2.4% | 0.0× | 0.93 |
Forecasts
3 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.
- Price target
- 6.13 USD · Analysts' mean
- EPS, year to Dec 2026
- 0.00 · 1 analyst
- Revenue, year to Dec 2026
- 48.21M · 4 analysts
Team and board
| Officer | Role |
|---|---|
| Adam Kalbermatten | President and Chief Executive Officer |
| Brian Hertzog | VP of Business Development |
| Rob Cannon | Vice President, Global Sales |
| Anna Majapuro-Hirvonen | Director, Global Medical and Clinical Affairs |
| Eric Schiller | Chief Technology Officer |
| Murat Sabah | Senior International Sales Manager |
Events
Calls
| Call | When | Status |
|---|---|---|
| KORU Medical Systems (NASDAQ:KRMD) Q3 2026 Earnings Call | Tue, Nov 10, 2026 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q2 2026 Earnings Call | Wed, Aug 05, 2026 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q1 2026 Earnings Call | Wed, May 06, 2026 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q4 2025 Earnings Call | Thu, Mar 12, 2026 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q3 2025 Earnings Call | Wed, Nov 12, 2025 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q2 2025 Earnings Call | Wed, Aug 06, 2025 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q1 2025 Earnings Call | Wed, May 07, 2025 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q4 2024 Earnings Call | Fri, Jan 10, 2025 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 4:30 PM ET | Replay |
| KORU Medical Systems (NASDAQ:KRMD) Q2 2024 Earnings Call | Wed, Aug 07, 2024 · 4:30 PM ET | Replay |
All 24 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 10, 2026 · After close | +23.1% |
| Q2 2026 | Aug 5, 2026 · After close | −13.8% |
| Q1 2026 | May 6, 2026 · After close | +10.7% |
| Q4 2025 | Mar 4, 2026 | −2.7% |
| Q3 2025 | Nov 12, 2025 · After close | +15.1% |
| Q2 2025 | Aug 6, 2025 · After close | +18.7% |
| Q1 2025 | May 7, 2025 · After close | +21.0% |
| Q4 2024 | Mar 12, 2025 | −13.2% |
| Q3 2024 | Nov 13, 2024 · After close | −3.8% |
| Q2 2024 | Aug 7, 2024 · After close | +16.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 1, 2024 · After close | +5.8% |
| Q4 2023 | Mar 13, 2024 · After close | +3.3% |
| Q3 2023 | Nov 8, 2023 · After close | −7.3% |
| Q2 2023 | Aug 9, 2023 · After close | +4.2% |
| Q1 2023 | May 4, 2023 · After close | −1.2% |
| Q4 2022 | Mar 8, 2023 · After close | −10.5% |
| Q3 2022 | Nov 9, 2022 · After close | +16.9% |
| Q2 2022 | Aug 3, 2022 · After close | +2.7% |
| Q1 2022 | May 4, 2022 · After close | −7.9% |
| Q4 2021 | Mar 2, 2022 · After close | −5.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 15 slides | Nov 10, 2026 |
| Investor Presentation (November 2026) | Investor deck | 15 slides | November 2026 |
| Lake Street BIG10 Conference 2026 | Conference | 18 slides | September 2026 |
| Q2 2026 Earnings Presentation | Earnings | 17 slides | Aug 5, 2026 |
| Investor Presentation (August 2026) | Investor deck | 16 slides | August 2026 |
| Q1 2026 Earnings Presentation | Earnings | 14 slides | May 6, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 19 slides | Mar 12, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 17 slides | Nov 12, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 17 slides | May 7, 2025 |
| Investor Presentation (January 2025) | Investor deck | 16 slides | Jan 13, 2025 |
All 20 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2024 Earnings Presentation | Earnings | 19 slides | Jan 10, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 15 slides | Nov 13, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 16 slides | Aug 7, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 14 slides | May 1, 2024 |
| Q4 2023 Earnings Presentation | Earnings | 15 slides | Mar 13, 2024 |
| Q3 2023 Earnings Presentation | Earnings | 17 slides | Nov 8, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 14 slides | Aug 9, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 16 slides | May 4, 2023 |
| Repro Med Systems — Investor Presentation (November 2020) | Investor deck | 18 slides | Nov 17, 2020 |
| Repro Med Systems — Investor Presentation (June 2020) | Investor deck | 25 slides | Jun 18, 2020 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.1M | 33.6M | 28.5M | 27.9M | 23.5M | 24.2M | 23.2M | 17.4M | 16.0M | 12.3M |
| Cost of revenue | 15.5M | 12.3M | 11.8M | 12.5M | 9.72M | 9.24M | 8.31M | 6.54M | 6.52M | 4.72M |
| Gross profit | 25.6M | 21.3M | 16.7M | 15.4M | 13.8M | 14.9M | 14.9M | 10.8M | 9.46M | 7.57M |
| Research and development | 4.39M | 5.26M | 5.74M | 4.96M | 2.47M | 1.30M | 740.5K | 241.1K | 60.7K | 237.5K |
| Selling, general and administrative | 23.4M | 21.6M | 20.4M | 20.6M | 17.9M | 12.0M | 9.77M | 8.20M | 7.73M | 7.77M |
| Operating income | -2.97M | -6.45M | -10.3M | -10.8M | -7.03M | -1.25M | 585.7K | 1.16M | 1.48M | -736.3K |
| Depreciation and amortization | 810.5K | 888.5K | 870.4K | 587.1K | 463.1K | 418.6K | 340.2K | 309.3K | 308.7K | 300.6K |
| EBITDA | -2.16M | -5.56M | -9.40M | -10.2M | -6.57M | -836.2K | 925.9K | 1.47M | 1.79M | -435.6K |
| Interest expense | 145.6K | 637.2K | 4.82M | 6.69M | 3.28K | 65.7K | 1.89K | |||
| Income before tax | -2.62M | -6.06M | -9.77M | -10.7M | -6.36M | 1.19M | 696.4K | 1.18M | 1.57M | -776.7K |
| Income tax | 21.9K | 2.89K | 3.97M | -2.01M | -1.80M | -17.8K | 132.1K | 266.4K | 483.1K | -241.7K |
| Net income | -2.64M | -6.07M | -13.7M | -8.66M | -4.56M | -1.21M | 564.3K | 910.6K | 1.09M | -535.0K |
| Earnings per share, basic | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 | -0.03 | 0.01 | 0.02 | 0.03 | -0.01 |
| Earnings per share, diluted | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 | -0.03 | 0.01 | 0.02 | -0.01 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.87M | 9.58M | 11.5M | 17.4M | 25.3M | 27.3M | 5.87M | 3.74M | 3.97M | 3.31M |
| Short-term investments | 1.52M | 263.3K | ||||||||
| Receivables | 6.21M | 5.72M | 4.05M | 3.56M | 3.59M | 2.57M | 3.23M | 1.43M | 1.86M | 1.50M |
| Inventory | 3.68M | 2.80M | 3.48M | 6.40M | 6.11M | 6.83M | 2.39M | 2.10M | 1.66M | 1.35M |
| Current assets | 20.0M | 19.1M | 20.3M | 29.8M | 37.3M | 37.5M | 11.9M | 9.03M | 7.93M | 6.78M |
| Property, plant and equipment | 4.47M | 4.29M | 3.84M | 3.89M | 1.11M | 1.17M | 611.8K | 858.8K | 836.3K | 932.1K |
| Total assets | 28.2M | 27.2M | 28.5M | 42.3M | 41.3M | 39.9M | 13.9M | 10.5M | 9.28M | 8.17M |
| Accounts payable | 2.27M | 1.65M | 975.2K | 2.39M | 1.23M | 624.9K | 572.7K | 453.5K | 454.4K | 772.4K |
| Current liabilities | 8.19M | 7.20M | 4.45M | 6.96M | 4.79M | 3.67M | 2.41M | 1.58M | 1.59M | 1.39M |
| Total debt | 3.50M | 3.99M | 4.45M | 4.93M | 604.1K | 239.5K | 381.7K | |||
| Total liabilities | 11.2M | 10.4M | 8.11M | 11.0M | 4.79M | 3.76M | 2.65M | 1.58M | 1.61M | 1.49M |
| Shareholders' equity | 17.0M | 16.8M | 20.4M | 31.3M | 36.5M | 36.2M | 11.2M | 8.96M | 7.67M | 6.68M |
| Shares outstanding | 46.4M | 46.0M | 45.7M | 45.4M | 44.6M | 43.3M | 39.5M | 38.2M | 38.4M | 37.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 462.4K | -319.7K | -4.89M | -5.40M | -4.32M | -743.3K | 320.6K | 1.48M | 899.9K | -331.6K |
| Capital spending | -932.5K | -1.30M | -782.9K | -2.76M | -346.2K | -920.6K | -201.2K | -297.0K | -218.3K | -203.1K |
| Free cash flow | -470.1K | -1.62M | -5.68M | -8.17M | -4.67M | -1.66M | 119.4K | 1.18M | 681.6K | -534.7K |
| Cash from investing | -949.8K | -1.33M | -814.6K | -2.80M | -366.2K | -1.04M | 1.31M | -1.73M | -219.3K | -416.3K |
| Cash from financing | -221.3K | -248.5K | -218.9K | 279.5K | 2.71M | 23.2M | 501.3K | 14.4K | -19.4K | -140.7K |
| Dividends paid | -184.8K | |||||||||
| Share buybacks | -97.4K | 406.6K | 0 | -3.50M | -2.82K | -36.8K | -19.4K | |||
| Change in cash | -708.7K | -1.90M | -5.93M | -7.93M | -1.98M | 21.4M | 2.13M | -235.7K | -227.4K | -888.7K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| S-3 · Registration statement | Nov 13, 2026 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Nov 10, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 10, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 14, 2026 | Current report | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 29, 2026 | Big-stake notice | SEC |
| 4/A · Change in ownership, amended | Jul 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 30, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jun 15, 2026 | Insider trade | SEC |
| 8-K · Current report | May 21, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 14, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 27, 2026 | Big-stake notice | SEC |
| DEF 14A · Proxy statement | Apr 9, 2026 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Apr 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 3, 2026 | Material contract | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 13, 2026 | Management or board change | SEC |
| 10-K · Annual report | Mar 12, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 12, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 10, 2026 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Jan 21, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 15, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 12, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jan 2, 2026 | Offer document | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 25, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 12, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Aug 12, 2025 | Offer document | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 11, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 8-K · Current report | May 15, 2025 | Meeting outcome | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 7, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 23, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 21, 2025 | Other filings | SEC |
| 8-K · Current report | Apr 7, 2025 | Management or board change | SEC |
| 8-K · Current report | Apr 4, 2025 | Material contract | SEC |
| DEF 14A · Proxy statement | Apr 4, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 17, 2025 | Other filings | SEC |
| S-8 POS | Mar 12, 2025 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Mar 12, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 12, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 12, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jan 21, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 13, 2025 | Results | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 3, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 3, 2025 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 13, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2024 | Results | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 21, 2024 | Management or board change | SEC |
| 8-K · Current report | Aug 7, 2024 | Results | SEC |
| 10-Q · Quarterly report | Aug 7, 2024 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Jul 31, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 26, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 24, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jul 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jul 10, 2024 | Offer document | SEC |
| S-8 POS | Jul 9, 2024 | Offer document | SEC |
| 8-K · Current report | Jun 3, 2024 | Current report | SEC |
| SC 13G · Big-stake notice | May 23, 2024 | Big-stake notice | SEC |
| 8-K · Current report | May 14, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 1, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 1, 2024 | Results | SEC |
| 8-K · Current report | Apr 11, 2024 | Current report | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
| DEF 14A · Proxy statement | Mar 28, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Mar 18, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 15, 2024 | Insider trade | SEC |
| 8-K · Current report | Mar 13, 2024 | Results | SEC |
| 10-K · Annual report | Mar 13, 2024 | Annual report | SEC |
| 4 · Change in ownership | Feb 16, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Dec 29, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 15, 2023 | Insider trade | SEC |
This page holds 200 of 971 filings. Open Filings
Cap table
Built by 6ix from KORU Medical Systems, Inc.’s releases · as of Sep 30, 2026
- Common shares
- 46,171,902
- Fully diluted
- 46,171,902
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 46,171,902 | Sep 30, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 46,171,902 |
| Sep 30, 2026 | 46,375,176 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joseph M Manko Jr Other companies: Myomo Inc. (Director · Since at least May 9, 2026); One Stop Systems, Inc. (Director · Nov 10, 2023 – Aug 13, 2024 · Past); Wireless Telecom Group Inc (Director · Jul 8, 2019 – Jun 4, 2020 · Past); Safeguard Scientifics, Inc. (Director · Mar 26, 2019 – Jan 30, 2024 · Past); Creative Realities, Inc. (Director · Sep 7, 2018 – Jan 8, 2020 · Past) | Director · Since at least Jun 1, 2016 |
| R. John Fletcher Other companies: ClearPoint Neuro Inc. (Director · Since at least Mar 29, 2019); OptiNose (Director · Apr 26, 2022 – May 21, 2025 · Past); Vyant Bio Inc (Director · Mar 30, 2021 – Jan 17, 2023 · Past); Axcelis Technologies, Inc. (Director · May 15, 2019 – Feb 17, 2021 · Past) | Director · Since at least May 7, 2019 |
| Robert Cascella Other companies: Celestica Inc. (Director · Since at least Dec 19, 2024); Mirion Technologies, Inc. (Director · Since at least Oct 20, 2021); Neuronetics, Inc. (Board Member · Since at least Apr 1, 2021); Hologic Inc (CEO and President, Director · Feb 1, 2006 – Jul 1, 2013 · Past) | Director · Since at least May 6, 2022 |
| Andrew LaFrence Other companies: SkyWater Technology, Inc. (Director · Since at least Mar 31, 2025); Nortech Systems Incorporated (Chief Financial Officer and Senior Vice President of Finance · Since at least Dec 1, 2023); Vyant Bio Inc (Chief Financial Officer · Mar 30, 2021 – Mar 15, 2022 · Past) | Chief Financial Officer · Jul 10, 2023 – Jul 15, 2023 · Past |
| Daniel S Goldberger Other companies: electroCore, Inc. (Chief Executive Officer, Director · Since at least Oct 1, 2019); Milestone Scientific, Inc. (President and CEO · Jul 10, 2017 – Aug 18, 2017 · Past); Xtant Medical Holdings, Inc. (Chief Executive Officer, Director · Aug 14, 2013 – Nov 14, 2016 · Past) | Director · Apr 23, 2018 – Mar 31, 2022 · Past |
| David W Anderson Other companies: Longevity Health Holdings, Inc. (Director · Jul 14, 2023 – Aug 28, 2024 · Past); PhotoMedex Inc (PHMD) (Director · Dec 8, 2010 – Jun 30, 2011 · Past); Cogentix Medical Inc (Director · Sep 2, 2010 – Jul 31, 2014 · Past) | Director · Feb 24, 2016 – Mar 31, 2022 · Past |
| Edward Wholihan Other companies: Allena Pharmaceuticals Inc (Chief Financial Officer · Nov 1, 2017 – Dec 17, 2020 · Past) | Director · Since at least Sep 28, 2023 |
| Linda M Tharby Other companies: Becton, Dickinson and Company (Executive Vice President · Oct 1, 2014 – Feb 1, 2018 · Past) | Chief Executive Officer, Director · Since at least Apr 12, 2021 |
| Adam Kalbermatten | Chief Commercial Officer · Since at least Jul 28, 2025 |
| Andrew I Sealfon | Director · Feb 28, 2009 – Dec 18, 2018 · Past |
All 34 people
| Person | Seat |
|---|---|
| Anna Majapuro-Hirvonen | Director, Global Medical and Clinical Affairs · Since at least Nov 4, 2026 |
| Arthur J Radin | Director · Jan 29, 2015 – Mar 29, 2019 · Past |
| Brad Alexander Sealfon | Director · Nov 29, 2013 – Jun 29, 2018 · Past |
| Brian Case | Chief Technology Officer · Apr 18, 2022 – May 2, 2022 · Past |
| Brian Hertzog | VP of Business Development · Since at least Nov 4, 2026 |
| Christopher Pazdan | Chief Operating Officer · Since at least Jul 18, 2024 |
| Donald B Pettigrew | Chief Executive Officer · Sep 4, 2018 – Dec 9, 2020 · Past |
| Donna French | Director · Since at least May 18, 2021 |
| Eric M Bauer | Chief Operating Officer · Jan 17, 2017 – Jan 17, 2017 · Past |
| Eric Schiller | Chief Technology Officer · Since at least Dec 16, 2025 |
| James M Beck | Director · Dec 5, 2018 – Jun 30, 2023 · Past |
| Karen Fisher | Chief Financial Officer · May 8, 2019 – Dec 7, 2020 · Past |
| Kathy Frommer | Director · Apr 23, 2019 – Mar 31, 2022 · Past |
| Kenneth E Miller | Chief Commercial Officer · Nov 6, 2023 – Mar 17, 2025 · Past |
| Manuel A Marques | Chief Operating Officer · Dec 5, 2018 – Dec 15, 2021 · Past |
| Mark L Pastreich | Director · Feb 18, 2011 – Jun 28, 2019 · Past |
| Michael Richard Boscher | Chief Financial Officer · Feb 6, 2012 – Feb 28, 2014 · Past |
| Murat Sabah | Senior International Sales Manager · Since at least Nov 4, 2026 |
| Paul Mark Baker | Director · Feb 28, 2009 – Dec 18, 2018 · Past |
| Rob Cannon | Vice President, Global Sales · Since at least Nov 4, 2026 |
| Robert T Allen | Director · Dec 5, 2018 – Mar 31, 2022 · Past |
| Ronald Tortorella | Cief Operating Officer · Feb 28, 2009 – Feb 28, 2009 · Past |
| Shahriar Matin | Director · Since at least May 18, 2021 |
| Thomas Edward Adams | Chief Financial Officer · Since at least Jul 1, 2022 |
Log in to ask 6ix AI your own questions about KORU Medical Systems, Inc.